MENU
+Compare
IONS
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$42.15
Change
-$0.00 (-0.00%)
Capitalization
6.72B

IONS Ionis Pharmaceuticals Forecast, Technical & Fundamental Analysis

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IONS with price predictions
Jul 25, 2025

IONS sees MACD Histogram crosses below signal line

IONS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 15, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IONS moved out of overbought territory on July 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IONS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IONS broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where IONS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on IONS as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IONS advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 189 cases where IONS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IONS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.124) is normal, around the industry mean (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). IONS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (9.001) is also within normal values, averaging (278.844).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IONS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IONS is expected to report earnings to fall 74.53% to -23 cents per share on July 30

Ionis Pharmaceuticals IONS Stock Earnings Reports
Q2'25
Est.
$-0.24
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.45
Q3'24
Beat
by $0.17
Q2'24
Beat
by $0.48
The last earnings report on April 30 showed earnings per share of -93 cents, beating the estimate of -108 cents. With 374.00 shares outstanding, the current market capitalization sits at 6.72B.
A.I. Advisor
published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLCIX20.500.12
+0.59%
Federated Hermes Kaufmann Large Cap IS
GCSSX25.600.14
+0.55%
Goldman Sachs Small Cap Eq Insghts Svc
RLEFX37.170.07
+0.19%
American Funds American Balanced R5E
RGSVX14.58-0.01
-0.07%
ClearBridge Global Infrastructure Inc IS
COCVX13.51-0.03
-0.22%
Columbia Overseas Value C

IONS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
N/A
ALNY - IONS
59%
Loosely correlated
N/A
IDYA - IONS
53%
Loosely correlated
-1.33%
XENE - IONS
50%
Loosely correlated
-2.29%
IMVT - IONS
50%
Loosely correlated
-7.48%
BEAM - IONS
49%
Loosely correlated
+3.68%
More